Labcorp Holdings Inc. (LON:0JSY)
London · Delayed Price · Currency is GBP · Price in USD 282.56
-1.45 (-0.51%)
At close: Oct 23, 2025
Labcorp Holdings Market Cap
Labcorp Holdings has a market cap or net worth of 17.72 billion as of October 24, 2025. Its market cap has increased by 29.81% in one year.
Market Cap
17.72B
Enterprise Value
22.20B
Revenue
9.84B
Ranking
n/a
PE Ratio
31.79
Stock Price
282.56
Market Cap Chart
Since July 20, 1992, Labcorp Holdings's market cap has increased from 1.07B to 17.72B, an increase of 1,550.85%. That is a compound annual growth rate of 8.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 17.72B | 15.63% |
| Dec 31, 2024 | 15.32B | 1.13% |
| Dec 29, 2023 | 15.15B | -12.51% |
| Dec 30, 2022 | 17.32B | -22.03% |
| Dec 31, 2021 | 22.21B | 52.93% |
| Dec 31, 2020 | 14.52B | 17.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 193.43B |
| GSK plc | 66.17B |
| Haleon | 31.07B |
| Smith & Nephew | 11.59B |
| ConvaTec Group | 4.84B |
| Hikma Pharmaceuticals | 3.95B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.74B |